Cargando…
Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy
OBJECTIVE: This study assessed the efficacy of INV-202, a novel peripherally restricted cannabinoid type-1 receptor (CB1R) inverse agonist, in a streptozotocin-induced type-1 diabetes nephropathy mouse model. METHODS: Diabetes was induced in 8-week-old C57BL6/J male mice via intraperitoneal injectio...
Autores principales: | Jacquot, Laetitia, Pointeau, Océane, Roger-Villeboeuf, Célia, Passilly-Degrace, Patricia, Belkaid, Rim, Regazzoni, Isaline, Leemput, Julia, Buch, Chloé, Demizieux, Laurent, Vergès, Bruno, Degrace, Pascal, Crater, Glenn, Jourdan, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479578/ https://www.ncbi.nlm.nih.gov/pubmed/37675364 http://dx.doi.org/10.3389/fneph.2023.1138416 |
Ejemplares similares
-
Orosensory Detection of Dietary Fatty Acids Is Altered in CB(1)R(−/−) Mice
por: Brissard, Léa, et al.
Publicado: (2018) -
Endocannabinoids Produced by White Adipose Tissue Modulate Lipolysis in Lean but Not in Obese Rodent and Human
por: Buch, Chloé, et al.
Publicado: (2021) -
Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist
por: Muller, Tania, et al.
Publicado: (2022) -
CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
por: Jourdan, Tony, et al.
Publicado: (2010) -
Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
por: Denimal, Damien, et al.
Publicado: (2023)